CT冠脉病变特征的预后价值随ASCVD风险而异:PROMISE试验启示
PROMISE试验纳入4356例稳定可疑CAD门诊患者,由核心实验室评估CAC、≥50%狭窄和高危斑块,比较不同ASCVD风险组中CT特征的预后价值。结果显示≥50%狭窄无论风险均有最高预后价值,CAC仅在高风险组、高危斑块仅在低风险组独立预测事件。
要点
- ≥50%狭窄的预后价值最高,且低ASCVD风险组HR高于高风险组。
- CAC仅在高ASCVD风险(≥7.5%)组独立预测事件。
- 高危斑块仅在低ASCVD风险(<7.5%)组独立预测事件。
核心结论
- CT来源的CAD特征预后价值因ASCVD风险类别而异,≥50%狭窄在低风险组预后价值更高。
- CAC仅在高ASCVD风险组预测事件,高危斑块仅在低ASCVD风险组预测事件。
- 对症状性低风险患者,检测≥50%狭窄和高危斑块而非CAC评分可能更好进行风险分层。
研究设计与样本
- PROMISE试验的事后分析,纳入4356例稳定可疑CAD门诊患者,中位随访2年。
- 核心实验室评估CAC、阻塞性CAD(狭窄≥50%)和高危斑块。
- 采用多变量Cox回归比较CT指标的HR,按合并队列方程计算的ASCVD风险分层(低-临界<7.5% vs 中-高≥7.5%)。
诊断标准与关键数值
- 阻塞性CAD定义为狭窄≥50%,总人群67%的ASCVD风险≥7.5%。
- 狭窄≥50%在ASCVD<7.5%组aHR 6.85(95%CI 2.33-20.15,p<0.001),在≥7.5%组aHR 2.66(95%CI 1.67-4.25,p<0.001),交互p=0.041。
- CAC在ASCVD≥7.5%组aHR 1.92(95%CI 1.01-3.63,p=0.045),交互p=0.571。
- 高危斑块在ASCVD<7.5%组aHR 3.11(95%CI 1.09-8.85,p=0.034),交互p=0.034。
临床应用与阅片要点
- 报告时应描述≥50%狭窄和高危斑块,尤其对低ASCVD风险患者。
- CAC评分在高ASCVD风险患者中仍有预后意义,但低风险患者中高危斑块更关键。
- 结合临床ASCVD风险评估CT特征,避免仅凭CAC评分对低风险患者进行风险分层。
局限性
- 原文未明确报告局限性,但为PROMISE试验的事后分析,中位随访仅2年。
- 事件数可能有限,部分亚组HR置信区间较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the prognostic value of individual CT-derived coronary artery disease (CAD) characteristics across categories of clinical cardiovascular risk.
METHODS: The central core laboratory assessed coronary artery calcium (CAC), obstructive CAD (stenosis ≥ 50%), and high-risk plaque (HRP) in stable outpatients with suspected CAD enrolled in the PROMISE trial. Multivariable Cox regression models (endpoint: unstable angina, nonfatal myocardial infarction, or all-cause mortality; median follow-up: 2 years) were used to compare hazard ratios (HR) of the CT measures between low-borderline (< 7.5%) and moderate-high (≥ 7.5%) atherosclerotic cardiovascular disease (ASCVD) risk based on the pooled cohort equation.
RESULTS: Among 4356 included patients (aged 61 ± 8 years, 52% women), 67% had ASCVD risk ≥ 7.5%. Stratified by ASCVD risk, CAD ≥ 50% had nearly threefold greater HR in individuals with ASCVD < 7.5% (aHR, 6.85; 95% CI, 2.33-20.15; p < 0.001) vs. ASCVD ≥ 7.5% (aHR: 2.66, 95% CI: 1.67-4.25, p < 0.001; interaction p = 0.041). CAC predicted events solely in ASCVD ≥ 7.5% patients (aHR: 1.92, 95% CI: 1.01-3.63, p = 0.045; interaction p = 0.571), while HRP predicted events only in ASCVD < 7.5% (aHR: 3.11, 95% CI: 1.09-8.85, p = 0.034; interaction p = 0.034).
CONCLUSIONS: Prognostic values of CT-derived CAD characteristics differ by ASCVD risk categories. While CAD ≥ 50% has the highest prognostic value regardless of ASCVD risk, CAC is prognostic in high and HRP in low ASCVD risk. These findings suggest that CAD ≥ 50% and HRP detection rather than CAC scoring may better risk-stratify symptomatic low-risk patients and thus potentially improve downstream care.
KEY POINTS: • Prognostic value of individual CT-derived CAD characteristics differs by categories of cardiovascular risk. • Presence of obstructive coronary artery stenosis ≥ 50% has the highest prognostic value regardless of cardiovascular risk. • Coronary artery calcium is independently prognostic in high and high-risk plaque features in low cardiovascular risk.
引用
- Foldyna, Mayrhofer, Lu, et al. Prognostic value of CT-derived coronary artery disease characteristics varies by ASCVD risk: insights from the PROMISE trial. Eur Radiol. 2023. PMID: 36719496. doi:10.1007/s00330-023-09430-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。